News Daily News FDA Expands CoreValve Indication to Include Intermediate-Risk Patients Michael O'Riordan July 10, 2017
News Daily News FDA Approves Amplatzer PFO Occluder for Prevention of Recurrent Stroke Yael L. Maxwell October 28, 2016
News Daily News TAVR as an Option for Intermediate-Risk Patients: Physicians Respond Yael L. Maxwell August 24, 2016
News Daily News Now You See It: FDA Approves Absorb Bioresorbable Scaffold Michael O'Riordan July 05, 2016